Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumors

Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumors

US Patent 11752096 · Granted Sep 12, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Extended local release of anti-CSFR1 antibodies2025
Extended local release of anti-CSFR1 antibodies2025
Extended local release of anti-CSFR1 antibodies2025
Antibodies that bind interleukin-2 and uses thereof2025
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
Corticotropin releasing factor receptor antagonists2024
Stable protein solution formulation containing high concentration of an anti-VEG2024
Methods for the treatment of abnormal involuntary movement disorders2024
System, method and computer-readable medium for rendering a streaming2024